<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29912900</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>HLA Class III: A susceptibility region to systemic lupus erythematosus in Tunisian population.</ArticleTitle><Pagination><StartPage>e0198549</StartPage><MedlinePgn>e0198549</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0198549</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0198549</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Short tandem repeats (STR) are usually used as informative polymorphic markers for genetic mapping and for disease susceptibility analysis. The involvement of these microsatellite markers localized in the MHC region was reported in many auto-immune diseases. In this study we analyzed for the first time eight polymorphisms of microsatellite loci at the HLA region: D6S291, D6S273, TNFa, b and c, MICA, D6S265 and D6S276, in Tunisian systemic lupus erythematosus (SLE) patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We performed a case control study in which the microsatellite loci were amplified using specific primers labeled with NED, VIC, PET or 6-FAM and analyzed using GeneScan software 3.7. For the statistical analysis, we used SPSS software and we performed a sub-haplotype scoring test using the haplo.stats software developed in the R language.</AbstractText><AbstractText Label="RESULTS">We found that two mean associated regions existed; the most statistically significant encompassed the 3 TNF markers (p = 0.0003, OR = 19.34); the latter covered the DR region. In fact, when scoring haplotypes in 3 marker- sliding windows, the p value increased as we moved away from the TNF region and decreased again when we approached the DRB1 locus. We also established for the first time the negative association between alleles of D6S291 and SLE. The majority of clinical and serological correlations were noted with TNF alleles.</AbstractText><AbstractText Label="CONCLUSION">Our results confirm the association between TNF and DRB1 polymorphisms and SLE. The association between alleles of D6S291 and SLE needs however to be verified by the analysis of other markers beyond this region.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hachicha</LastName><ForeName>Hend</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5819-2899</Identifier><AffiliationInfo><Affiliation>Immunology Department, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Sfax, University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahfoudh</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Histocompatibility Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fourati</LastName><ForeName>Hajer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elloumi</LastName><ForeName>Nesrine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzouk</LastName><ForeName>Sameh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hedi Chaker University Hospital of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feki</LastName><ForeName>Sawsan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunology Department, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakhfakh</LastName><ForeName>Raouia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frikha</LastName><ForeName>Faten</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hedi Chaker University Hospital of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayadi</LastName><ForeName>Abir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maatoug</LastName><ForeName>Amira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaddour</LastName><ForeName>Lilia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Histocompatibility Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakim</LastName><ForeName>Feiza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Histocompatibility Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahloul</LastName><ForeName>Zouheir</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hedi Chaker University Hospital of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makni</LastName><ForeName>Hafedh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Histocompatibility Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masmoudi</LastName><ForeName>Hatem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Immunology Department, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UR12SP14, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammoun</LastName><ForeName>Arwa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Histocompatibility Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018895" MajorTopicYN="N">Microsatellite Repeats</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014416" MajorTopicYN="N" Type="Geographic">Tunisia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29912900</ArticleId><ArticleId IdType="pmc">PMC6005577</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0198549</ArticleId><ArticleId IdType="pii">PONE-D-17-35365</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arnett FC, Goldstein R, Duvic M, Reveille JD. Major histocompatibility complex genes in systemic lupus erythematosus, Sjogren&#x2019;s syndrome, and polymyositis. (Review). Am J Med 85 (1988) 38&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">2462349</ArticleId></ArticleIdList></Reference><Reference><Citation>Abida O, Mahfoudh N, Kammoun A, Gaddour L, Hakim F, Toumi A
et al.
Polymorphisms of HLA microsatellite marker in Tunisian pemphigus foliaceus. Hum Immunol. 74(1) (2013) 104&#x2013;9. doi: 10.1016/j.humimm.2012.10.013
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2012.10.013</ArticleId><ArticleId IdType="pubmed">23073295</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn&#x2019;s disease (CD): influence on disease behaviour? ClinExp Immunol 119 (2000) 64&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1905519</ArticleId><ArticleId IdType="pubmed">10606965</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, G&#xfc;nther C, Lee-Kirsch MA. Innate immune processes in lupus erythematosus. . 147(3) (2013) 216&#x2013;22. doi: 10.1016/j.clim.2012.11.012
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2012.11.012</ArticleId><ArticleId IdType="pubmed">23290784</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o-Rodr&#xed;guez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmunity Reviews. 7 (2008) 322&#x2013;330
doi: 10.1016/j.autrev.2007.12.002
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2007.12.002</ArticleId><ArticleId IdType="pubmed">18295738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rellea M, Weinmann-Menkea J, Scorlettib E, Cavagna L, Schwartinga A. Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmunity Reviews. 14 (2015) 1005&#x2013;1018
doi: 10.1016/j.autrev.2015.07.003
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.07.003</ArticleId><ArticleId IdType="pubmed">26164648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachicha H, Kammoun A, Mahfoudh N, Marzouk S, Feki S, Fakhfakh R, et al. HLA-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in south Tunisia. Int J HealthSci (Qassim). 2018. Jan-Feb;12(1):21&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870315</ArticleId><ArticleId IdType="pubmed">29623013</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnetche T, Constantin A, Gourraud P-A, Abbal M, Garnier JG, Cantagrel A
et al.
Microsatellite typingof the human leucocyte antigen region: analytical approach and contributionto rheumatoid arthritis immunogenetic studies. Tissue Antigens 2006;68: 390&#x2013;8. doi: 10.1111/j.1399-0039.2006.00693.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2006.00693.x</ArticleId><ArticleId IdType="pubmed">17092252</ArticleId></ArticleIdList></Reference><Reference><Citation>Pociot F, Briant L, Jongeneel CV, M&#xf6;lvig J, Worsaae H, Abbal M
et al.
Association of tumor necrosis factor(TNF) and class II major histocompatibility complex alleles with the secretionof TNF-alpha and TNF-beta by human mononuclear cells: a possible link toinsulin-dependent diabetes mellitus. Eur J Immunol
1993;23:224&#x2013;31. doi: 10.1002/eji.1830230135
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830230135</ArticleId><ArticleId IdType="pubmed">8093442</ArticleId></ArticleIdList></Reference><Reference><Citation>Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S et al. Systemic lupus erythematosus and the extended major histocompatibility complex&#x2014;evidence for several predisposing loci. Rheumatology (Oxford). 44(11) (2005) 1368&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">16174649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EY, Yim JJ, Lee HS, Lee YJ, Lee EB, Song YW. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int J Immunogenet
33(3) (2006) 211&#x2013;5. doi: 10.1111/j.1744-313X.2006.00599.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-313X.2006.00599.x</ArticleId><ArticleId IdType="pubmed">16712654</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla-Costa R, Pincerati MR, Beltrame MH, Malheiros D, Petzl-Erler ML. Polymorphisms in the 2q33 and 3q21 chromosome regions including T-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus. Hum Immunol
71 (2010) 809&#x2013;17. doi: 10.1016/j.humimm.2010.04.001
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2010.04.001</ArticleId><ArticleId IdType="pubmed">20433886</ArticleId></ArticleIdList></Reference><Reference><Citation>Shai R, Quismorio FP Jr, Li L, Kwon OJ, Morrison J, Wallace DJ et al. "Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families." Human Molecular Genetics 84 (1999): 639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">10072432</ArticleId></ArticleIdList></Reference><Reference><Citation>Novota P, Kolesa L, Slavcev A, Cerna M. Fluorescence based automated fragment analysis of microsatellite polymorphism within the transmembrane region of the MICA-A gene. Folia Biologica 50 (2004) 21&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">15055739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E, Torres B, Vilches JR, Lopez-Nevot MA, Ortego-Centeno N, Jimenez-Alonso J
et al.No primary association of MICA polymorphism with systemic lupus erythematosus. Rheumatology. 45 (2006) 1096&#x2013;1100
doi: 10.1093/rheumatology/kel058
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel058</ArticleId><ArticleId IdType="pubmed">16537577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambelunghe G, Gerli R, BartoloniBocci E, Del Sindaco P, Ghaderi M, Sanjeevi CB
et al.A. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology. 44 (2005) 287&#x2013;292
doi: 10.1093/rheumatology/keh459
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keh459</ArticleId><ArticleId IdType="pubmed">15522921</ArticleId></ArticleIdList></Reference><Reference><Citation>Fojt&#x131;&#xb4;kova&#xb4; M, Novota P, C &#x2c7; ejkova&#xb4; P, Pes&#x2c7;ic&#x2c7;kova&#xb4; S, Tegzova D and C &#x2c7; erna M. HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population. RheumatolInt 31 (2011) 1195&#x2013;1201</Citation><ArticleIdList><ArticleId IdType="pubmed">20352225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Komai K, Shiozawa K, Mashida A, Horiuchi T, Tanaka Y et al. Role of the MICA Polymorphism in Systemic Lupus Erythematosus. Arthritis &amp;rheumatism 63(10) (2011) 3058&#x2013;3066</Citation><ArticleIdList><ArticleId IdType="pubmed">21702010</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM
et al.
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum
60 (2009) 1753&#x2013;63. doi: 10.1002/art.24556
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24556</ArticleId><ArticleId IdType="pubmed">19479851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Graham J, Mc Neeny B, Zarghami M, Landin-Olsson M, Hagopian WA
et al.
MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Ann N Y Acad Sci. 1079 (2006) 229&#x2013;39. doi: 10.1196/annals.1375.036
</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1375.036</ArticleId><ArticleId IdType="pubmed">17130560</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Linden MW, Van Der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GMTh et al.
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF&#x3b1;308A in systemic lupus erythematosus
Genes Immun, 2 (7) (2001) 373&#x2013;380
doi: 10.1038/sj.gene.6363794
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6363794</ArticleId><ArticleId IdType="pubmed">11704803</ArticleId></ArticleIdList></Reference><Reference><Citation>Naves M, Hajeer AH, Teh LS, Davies EJ, Ordi-Ros J, Perez-Pemen P et al. Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population. Eur J Immunogenet. 25 (4) (1998) 317&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">9777334</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens. 47(6) (1996) 551&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8813745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K. Analysis of the association of HLA-DRB1, TNF&#x3b1; promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun. 2001. 
October;2(6):317&#x2013;22
doi: 10.1038/sj.gene.6363783
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6363783</ArticleId><ArticleId IdType="pubmed">11607787</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B
et al.
Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans
Am J Hum Genet. 2007. 
June;80(6):1037&#x2013;54
doi: 10.1086/518257
</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518257</ArticleId><ArticleId IdType="pmc">PMC1867093</ArticleId><ArticleId IdType="pubmed">17503323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajeer AH, Worthington J, Davies EJ, Hillarby MC, Poulton K, Ollier WER. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythernatosus. Tissue Antigens 49 (1997) 222&#x2013;227</Citation><ArticleIdList><ArticleId IdType="pubmed">9098928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarassi K, Carthy D, Papasteriades C, Boki K, Nikolopoulou N, Carcassi C et al.HLA-TNF haplotype heterogeneity in Greek SLE patients.ClinExpRheumatol. 16(1) (1998) 66&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">9543565</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>